AAAAAA

   
Results: 1-6 |
Results: 6
ANTIBODY FRAGMENTS IN RADIOIMMUNOTHERAPY (RIT) - THE ROLE OF THE RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY
Authors: BEHR TM MEMTSOUDIS S SHARKEY RM BLUMENTHAL RD DUNN RM GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., ANTIBODY FRAGMENTS IN RADIOIMMUNOTHERAPY (RIT) - THE ROLE OF THE RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, The Journal of nuclear medicine, 39(5), 1998, pp. 439-439
EXPERIMENTAL STUDIES ON THE ROLE OF ANTIBODY FRAGMENTS IN CANCER RADIO-IMMUNOTHERAPY - INFLUENCE OF RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY
Authors: BEHR TM MEMTSOUDIS S SHARKEY RM BLUMENTHAL RD DUNN RM GRATZ S WIELAND E NEBENDAHL K SCHMIDBERGER H GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., EXPERIMENTAL STUDIES ON THE ROLE OF ANTIBODY FRAGMENTS IN CANCER RADIO-IMMUNOTHERAPY - INFLUENCE OF RADIATION-DOSE AND DOSE-RATE ON TOXICITY AND ANTITUMOR EFFICACY, International journal of cancer, 77(5), 1998, pp. 787-795
THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VS.BETA-EMITTER IN RADIOIMMUNOTHERAPY WITH INTERNALIZING ANTIBODIES - EVALUATION OF I-125-LABELED VS I-131-LABELED CO17-1A IN A HUMAN COLORECTAL-CANCER MODEL
Authors: BEHR TM SGOUROS G VOUGIOUKAS V MEMTSOUDIS S GRATZ S SCHMIDBERGER H BLUMENTHAL RD GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VS.BETA-EMITTER IN RADIOIMMUNOTHERAPY WITH INTERNALIZING ANTIBODIES - EVALUATION OF I-125-LABELED VS I-131-LABELED CO17-1A IN A HUMAN COLORECTAL-CANCER MODEL, International journal of cancer, 76(5), 1998, pp. 738-748
RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER IN MINIMAL RESIDUAL DISEASE AND IN AN ADJUVANT SETTING - EVALUATION OF I-131-LABELED AND Y-90-LABELED IGG AND FRAGMENTS VERSUS STANDARD CHEMOTHERAPY IN A NUDE-MOUSE MODEL
Authors: BEHR TM MEMTSOUDIS S BLUMENTHAL RD DUNN RM NEBENDAHL K SHARKEY RM GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER IN MINIMAL RESIDUAL DISEASE AND IN AN ADJUVANT SETTING - EVALUATION OF I-131-LABELED AND Y-90-LABELED IGG AND FRAGMENTS VERSUS STANDARD CHEMOTHERAPY IN A NUDE-MOUSE MODEL, The Journal of nuclear medicine, 38(5), 1997, pp. 14-14
THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VERSUS BETA-EMITTER IN RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER WITH INTERNALIZING ANTIBODIES
Authors: BEHR TM MEMTSOUDIS S VOUGIOUKAS V GRATZ S NEBENDAHL K BECKER W
Citation: Tm. Behr et al., THERAPEUTIC EFFICACY AND DOSE-LIMITING TOXICITY OF AUGER-ELECTRON VERSUS BETA-EMITTER IN RADIOIMMUNOTHERAPY OF COLORECTAL-CANCER WITH INTERNALIZING ANTIBODIES, The Journal of nuclear medicine, 38(5), 1997, pp. 16-16
COMPLETE VERSUS FRAGMENTED, I-131-LABELED AND Y-90-LABELED ANTIBODIESFOR RADIOIMMUNOTHERAPY (RAIT) OF CEA-EXPRESSING CANCERS - INFLUENCE OF DOSE-RATE AND RENAL ACCRETION ON TOXICITY AND ANTI-TUMOR-EFFICACY
Authors: BEHR TM MEMTSOUDIS S BLUMENTHAL RD DUNN RM SHARKEY RM GOLDENBERG DM BECKER W
Citation: Tm. Behr et al., COMPLETE VERSUS FRAGMENTED, I-131-LABELED AND Y-90-LABELED ANTIBODIESFOR RADIOIMMUNOTHERAPY (RAIT) OF CEA-EXPRESSING CANCERS - INFLUENCE OF DOSE-RATE AND RENAL ACCRETION ON TOXICITY AND ANTI-TUMOR-EFFICACY, The Journal of nuclear medicine, 38(5), 1997, pp. 107-107
Risultati: 1-6 |